Medicis downgraded to Neutral from Positive at Susquehanna Medicis (MRX) is being acquire3d by Valeant Pharmaceuticals (VRX) for $44 per share and Susquehanna does not expect another bidder to emerge.
News For MRX From The Last 14 Days
Check below for free stories on MRX the last two weeks.
